4.6 Article

Longer Telomere Length in COPD Patients with α1-Antitrypsin Deficiency Independent of Lung Function

Journal

PLOS ONE
Volume 9, Issue 4, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0095600

Keywords

-

Funding

  1. Alpha-1 Foundation
  2. CHEST Foundation Clinical Research Award
  3. Michael Smith Foundation for Health Research Senior Scholarship award

Ask authors/readers for more resources

Oxidative stress is involved in the pathogenesis of airway obstruction in alpha(1)-antitrypsin deficient patients. This may result in a shortening of telomere length, resulting in cellular senescence. To test whether telomere length differs in alpha(1)-antitrypsin deficient patients compared with controls, we measured telomere length in DNA from peripheral blood cells of 217 alpha(1)-antitrypsin deficient patients and 217 control COPD patients. We also tested for differences in telomere length between DNA from blood and DNA from lung tissue in a subset of 51 controls. We found that telomere length in the blood was significantly longer in alpha(1)-antitrypsin deficient COPD patients compared with control COPD patients (p = 1x10(-29)). Telomere length was not related to lung function in alpha(1)-antitrypsin deficient patients (p = 0.3122) or in COPD controls (p = 0.1430). Although mean telomere length was significantly shorter in the blood when compared with the lungs (p = 0.0078), telomere length was correlated between the two tissue types (p = 0.0122). Our results indicate that telomere length is better preserved in alpha(1)-antitrypsin deficient COPD patients than in non-deficient patients. In addition, measurement of telomere length in the blood may be a suitable surrogate for measurement in the lung.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available